The insulin-like growth factor-1 receptor-targeting antibody, CP-751,871, suppresses tumor-derived VEGF and synergizes with rapamycin in models of childhood sarcoma

Raushan T. Kurmasheva, Lorina Dudkin, Catherine Billups, Larisa V. Debelenko, Christopher L. Morton, Peter J. Houghton

Research output: Contribution to journalArticlepeer-review

138 Scopus citations

Fingerprint

Dive into the research topics of 'The insulin-like growth factor-1 receptor-targeting antibody, CP-751,871, suppresses tumor-derived VEGF and synergizes with rapamycin in models of childhood sarcoma'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences

Chemistry